If this page doesn't display properly in your email, Click here

June 30, 2008


Updated Blastomycosis Guidelines Feature New Treatments

New guidelines on the management of blastomycosis include several new therapies developed since the 2000 edition was published....Read Full Article



New Pre-pandemic Vaccine Highlights Progress, Raises Questions

The European Union has approved its first pre-pandemic vaccine, targeted against H5N1 influenza. The question now becomes, in the absence of a pandemic, how widely should these vaccines be used? ...Read Full Article



IDSA Journal Club, June 2008

In this new feature, a panel of IDSA members identifies and critiques important new infectious diseases studies in the current literature that have a significant impact on the practice of infectious diseases medicine....Read Full Article



In the IDSA Journals

Summaries of selected research published in the May issues of The Journal of Infectious Diseases and Clinical Infectious Diseases. ...Read Full Article



Drug Approvals, Recalls, Adverse Events Update

Recent messages from IDSA's FDA and CDC alert services....Read Full Article



EIN: What to Do About Hepatitis B Vaccine Non-responders

An EIN member’s patient had not developed an immune response after two complete series of hepatitis B vaccine. The member asked for advice on additional measures to generate seroconversion, including the possibility of intradermal administration. The following is a sampling of the responses....Read Full Article



NIAID Solicits Clinical Trials Proposals to Reduce the Risk of Antimicrobial Resistance

The clinical trials NIAID has requested closely reflect recommendations IDSA made to the institute last summer....Read Full Article



New Coding Resource Helps Clinicians Choose Appropriate Service Codes

IDSA’s Clinical Affairs Committee has developed a new resource to help members and their billing staffs choose the appropriate level of evaluation and management (E&M) service code....Read Full Article



CMS Releases Problematic New List of Hospital-acquired Conditions

As Medicare prepares to stop reimbursing hospitals for certain hospital acquired conditions, IDSA and SHEA continue to advocate a cautious approach that protects patient safety without resulting in unintended consequences....Read Full Article



FDA Moves to Update Antibacterial Breakpoints

The Food and Drug Administration (FDA) has proposed a streamlined process for updating breakpoints of antibacterials, a move intended to help correct outdated information that clinicians rely on to predict what therapies are likely to be successful for treating infections....Read Full Article



IDSA Advocacy Update: IDSA Opposes HHS Proposal for Home Stockpiling of Doxycycline

...Read Full Article



New Book Addresses Questions about Vaccine Safety

...Read Full Article



New Desktop Software for Keeping Kids on Track with Immunizations

...Read Full Article



IDSA Holds First Fellows’ In-Training Exam

...Read Full Article



Members on the Move

...Read Full Article



Welcome, New IDSA Members!

...Read Full Article

Updated Blastomycosis Guidelines Feature New Treatments
New Pre-pandemic Vaccine Highlights Progress, Raises Questions
IDSA Journal Club, June 2008
In the IDSA Journals
Drug Approvals, Recalls, Adverse Events Update
EIN: What to Do About Hepatitis B Vaccine Non-responders
NIAID Solicits Clinical Trials Proposals to Reduce the Risk of Antimicrobial Resistance
New Coding Resource Helps Clinicians Choose Appropriate Service Codes
CMS Releases Problematic New List of Hospital-acquired Conditions
FDA Moves to Update Antibacterial Breakpoints
IDSA Advocacy Update: IDSA Opposes HHS Proposal for Home Stockpiling of Doxycycline
New Book Addresses Questions about Vaccine Safety
New Desktop Software for Keeping Kids on Track with Immunizations
IDSA Holds First Fellows’ In-Training Exam
Members on the Move
Welcome, New IDSA Members!


Search Back Issues
Forward this Issue
Print-Friendly Version
Unsubscribe

© Copyright IDSA 2008 Infectious Diseases Society of America 1300 Wilson Boulevard, Suite 300 Arlington, VA 22209 info@idsociety.org

To ensure delivery of IDSA News please add idsanews@idsociety.org to your email address book or Safe Sender List. If you are still having
problems receiving our communications, see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm

Home Page Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA